Prospect

Today on TAP: Is there anything capitalism can’t co-opt?

The econ blogosphere hasn’t really checked, but knows in its heart American workers aren’t up to the job.

The e-commerce company is a principal member of the trade group lobbying the Treasury Department for looser rules on the emerging fuel.

Aaron Regunberg has left-wing endorsements; Lt. Gov. Sabina Matos, more centrist ones. But Matos is fending off a series of scandals.

Today on TAP: The gulf between urban, suburban, and rural counties in Tuesday’s vote was, well, total.

Stock in Medical Properties Trust tanked 14 percent this week after a couple of eyebrow-raising disclosures.

Automakers switching to Tesla’s charging plug opens up more opportunities in the short term, but problems in the long term.

Biden administration officials and some congressional leaders want federal employees back in their offices. But flexible schedules are here to stay.

Today on TAP: Red-state voters reject both a ham-handed move to undermine democracy as well as abortion restrictions.

The trucking company alleges the Teamsters used the company as a sacrificial lamb.

Entertainment workers are organizing across the board.

Hickory, North Carolina, is home to nearly half of the country’s fiber-optic cable production, which is growing because of the Biden infrastructure law.

His legal strategy is to gum up the process until after the election. It will probably work.

Elliott Management is asking FERC to let it purchase up to one-fifth of the common stock in a Texas utility.

Today on TAP: The UAW is asking the Big Three automakers to raise wages by the same percentage that their CEOs’ pay has risen.

Look past the headline numbers and the story begins to emerge. Whether Biden’s strategy can outlast this rough patch is another question.

Thanks to an ill-considered move by Joe Biden and the DNC, several fringe Democrats will be on the ballot in the nation’s first primary, and the president will be on the sidelines.

A surge of federal funding from the American Rescue Plan has helped cities develop pilot guaranteed income programs. Will they last?

Today on TAP: Exhibit A is the case of the EpiPen. It should cost a few dollars rather than the $600 or more charged by monopolist Viatris.

Extreme inequality is bad for billionaires and ordinary citizens alike.